TAK
Takeda Pharmaceutical Co Ltd ADR
NYSE: TAK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.68
+2.33% today
Updated 2026-04-30
Market cap
$52.54B
P/E ratio
75.59
P/S ratio
0.01x
EPS (TTM)
$0.22
Dividend yield
3.98%
52W range
$13 – $19
Volume
2.8M
Takeda Pharmaceutical Co Ltd ADR (TAK) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.21T | $1.31T | $1.37T | $1.54T | $1.47T | $1.42T | $1.51T | $1.56T | $1.69T | $1.78T | $1.81T | $1.73T | $1.77T | $2.10T | $3.29T | $3.20T | $3.57T | $4.03T | $4.26T | $4.58T |
| Revenue growth (YoY) | — | +7.7% | +5.3% | +11.9% | -4.7% | -3.2% | +6.3% | +3.2% | +8.6% | +5.1% | +1.7% | -4.2% | +2.2% | +18.5% | +56.9% | -2.8% | +11.6% | +12.8% | +5.9% | +7.5% |
| Cost of revenue | $282.10B | $279.66B | $278.63B | $289.54B | $285.06B | $317.58B | $433.19B | $447.63B | $490.26B | $520.99B | $535.40B | $558.75B | $495.92B | $659.69B | $1.09T | $994.31B | $1.11T | $1.24T | $1.43T | $1.58T |
| Gross profit | $930.11B | $1.03T | $1.10T | $1.25T | $1.18T | $1.10T | $1.08T | $1.11T | $1.20T | $1.26T | $1.27T | $1.17T | $1.27T | $1.44T | $2.20T | $2.20T | $2.46T | $2.78T | $2.83T | $3.00T |
| Gross margin | 76.7% | 78.6% | 79.7% | 81.2% | 80.6% | 77.6% | 71.3% | 71.3% | 71.0% | 70.7% | 70.4% | 67.7% | 72.0% | 68.5% | 66.9% | 68.9% | 69.0% | 69.1% | 66.4% | 65.5% |
| R&D | — | — | — | — | — | — | — | $324.29B | $341.56B | $382.10B | $345.93B | $312.30B | $325.44B | $368.30B | $492.38B | $455.83B | $526.09B | $633.33B | $729.92B | $730.23B |
| SG&A | — | — | — | $834.23B | $666.68B | $640.20B | $810.71B | $811.62B | $450.96B | $499.40B | $650.77B | $619.06B | $628.11B | $717.60B | $964.74B | $875.66B | $886.36B | $997.31B | $1.05T | $1.10T |
| Operating income | $402.81B | $458.50B | $423.12B | $306.47B | $420.21B | $367.08B | $265.03B | $122.50B | $139.27B | $-129.25B | $130.83B | $155.87B | $241.79B | $204.97B | $100.41B | $509.27B | $460.84B | $490.50B | $214.07B | $342.59B |
| Operating margin | 33.2% | 35.1% | 30.8% | 19.9% | 28.7% | 25.9% | 17.6% | 7.9% | 8.2% | -7.3% | 7.2% | 9.0% | 13.7% | 9.8% | 3.1% | 15.9% | 12.9% | 12.2% | 5.0% | 7.5% |
| EBITDA | $547.05B | $654.45B | $608.87B | $518.25B | $532.08B | $479.63B | $404.56B | $351.18B | $368.18B | $57.29B | $349.85B | $296.88B | $359.96B | $464.22B | $671.90B | $983.72B | $1.18T | $1.28T | $1.14T | $1.21T |
| EBITDA margin | 45.1% | 50.1% | 44.3% | 33.7% | 36.3% | 33.8% | 26.8% | 22.6% | 21.8% | 3.2% | 19.4% | 17.1% | 20.3% | 22.1% | 20.4% | 30.8% | 33.2% | 31.9% | 26.8% | 26.4% |
| EBIT | $518.32B | $625.63B | $577.17B | $400.17B | $417.26B | $372.91B | $254.36B | $150.07B | $152.44B | $-203.66B | $152.47B | $125.45B | $177.83B | $216.53B | $88.26B | $424.05B | $600.06B | $619.67B | $499.48B | $449.12B |
| Interest expense | $365.00M | $247.00M | $333.00M | $1.62B | $1.43B | $1.33B | $1.88B | $3.32B | $30.72B | $32.88B | $31.93B | $23.25B | $31.93B | $48.16B | $1.46B | $130.81B | $122.43B | $116.97B | $1.06B | $137.31B |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $313.25B | $335.81B | $355.45B | $234.38B | $297.74B | $247.87B | $124.16B | $131.24B | $106.66B | $-145.78B | $80.17B | $114.94B | $186.89B | $109.13B | $44.24B | $376.00B | $230.06B | $317.02B | $144.07B | $107.93B |
| Net income growth (YoY) | — | +7.2% | +5.9% | -34.1% | +27.0% | -16.8% | -49.9% | +5.7% | -18.7% | -236.7% | +155.0% | +43.4% | +62.6% | -41.6% | -59.5% | +749.9% | -38.8% | +37.8% | -54.6% | -25.1% |
| Profit margin | 25.8% | 25.7% | 25.9% | 15.2% | 20.3% | 17.5% | 8.2% | 8.4% | 6.3% | -8.2% | 4.4% | 6.6% | 10.6% | 5.2% | 1.3% | 11.8% | 6.4% | 7.9% | 3.4% | 2.4% |